Decreased circulating klotho levels in patients undergoing dialysis and relationship to oxidative stress and inflammation.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 24497597)

Published in Perit Dial Int on February 04, 2014

Authors

Hyung Jung Oh1, Bo Young Nam1, Mi Jung Lee1, Chan Ho Kim1, Hyang Mo Koo1, Fa Mee Doh1, Jae Hyun Han1, Eun Jin Kim1, Ji Suk Han1, Jung Tak Park1, Tae-Hyun Yoo1, Shin-Wook Kang2, Dae-Suk Han1, Seung Hyeok Han1

Author Affiliations

1: Division of Nephrology, Department of Internal Medicine, College of Medicine, Brain Korea 21, Severance Biomedical Science Institute, Yonsei University, Seoul, Korea.
2: Division of Nephrology, Department of Internal Medicine, College of Medicine, Brain Korea 21, Severance Biomedical Science Institute, Yonsei University, Seoul, Korea Division of Nephrology, Department of Internal Medicine, College of Medicine, Brain Korea 21, Severance Biomedical Science Institute, Yonsei University, Seoul, Korea.

Articles cited by this

Validation of a combined comorbidity index. J Clin Epidemiol (1994) 19.43

Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature (1997) 13.77

Suppression of aging in mice by the hormone Klotho. Science (2005) 8.11

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int (2006) 7.02

Regulation of fibroblast growth factor-23 signaling by klotho. J Biol Chem (2006) 6.50

K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis (2005) 6.31

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int (2002) 4.29

Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr (1980) 4.00

Premature cardiovascular disease in chronic renal failure. Lancet (2000) 3.17

Regulation of oxidative stress by the anti-aging hormone klotho. J Biol Chem (2005) 2.94

Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl (2008) 2.70

Severely reduced production of klotho in human chronic renal failure kidney. Biochem Biophys Res Commun (2001) 2.63

Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun (2010) 2.20

In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension (2002) 1.88

Klotho as a regulator of fibroblast growth factor signaling and phosphate/calcium metabolism. Curr Opin Nephrol Hypertens (2006) 1.81

Circulating α-klotho levels in CKD and relationship to progression. Am J Kidney Dis (2013) 1.76

Klotho as a regulator of oxidative stress and senescence. Biol Chem (2008) 1.68

Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol (2004) 1.65

Current understanding of klotho. Ageing Res Rev (2008) 1.64

Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrol Dial Transplant (2005) 1.55

Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nat Cell Biol (2011) 1.55

Oxidative stress decreases klotho expression in a mouse kidney cell line. Nephron Exp Nephrol (2005) 1.44

Klotho depletion contributes to increased inflammation in kidney of the db/db mouse model of diabetes via RelA (serine)536 phosphorylation. Diabetes (2011) 1.35

Downregulation of the Klotho gene in the kidney under sustained circulatory stress in rats. Biochem Biophys Res Commun (1998) 1.30

Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. Clin Exp Nephrol (2012) 1.28

Decreased renal α-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion. Kidney Int (2012) 1.19

Oxidative stress in uremia. Curr Opin Nephrol Hypertens (2003) 1.18

Predictive cardiovascular risk factors in patients with chronic kidney disease (CKD). Kidney Int Suppl (2005) 1.07

Linkage of some trace elements, peripheral blood lymphocytes, inflammation, and oxidative stress in patients undergoing either hemodialysis or peritoneal dialysis. Perit Dial Int (2010) 1.04

Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant (2001) 0.99

Iron chelation and a free radical scavenger suppress angiotensin II-induced downregulation of klotho, an anti-aging gene, in rat. FEBS Lett (2003) 0.93

Klotho, phosphate and inflammation/ageing in chronic kidney disease. Nephrol Dial Transplant (2012) 0.92

Morbidity and mortality in dialysis patients. Kidney Int (1994) 0.92

The relationship between the soluble Klotho protein and the residual renal function among peritoneal dialysis patients. Clin Exp Nephrol (2012) 0.91

8-iso-prostaglandin F2alpha as a useful clinical biomarker of oxidative stress in ESRD patients. Blood Purif (2002) 0.90

Antioxidant status of patients on peritoneal dialysis: associations with inflammation and glycoxidative stress. Perit Dial Int (2009) 0.89

Patient mortality and survival. United States Renal Data System. Am J Kidney Dis (1998) 0.86

Isoprostanes--markers of ischaemia reperfusion injury. Eur J Anaesthesiol (2002) 0.80

Serum soluble Klotho protein level is associated with residual diuresis in incident peritoneal dialysis patients. Acta Biochim Pol (2013) 0.77